Guanine
| Guanine | |
|---|---|
| IUPAC name | 2-amino-1H-purin-6(9H)-one |
| Other names | 2-amino-6-oxo-purine, 2-aminohypoxanthine, Guanine |
| Identifiers | |
| CAS number | |
| RTECS number | MF8260000 |
| SMILES | NC1=Nc2[nH]cnc2C(=O)N1 |
| Properties | |
| Molecular formula | C5H5N5O |
| Molar mass | 151.1261 g/mol |
| Appearance | White amorphous solid. |
| Density | , solid. |
| Melting point |
360°C (633.15 K) deco. |
| Boiling point |
Sublimes. |
| Solubility in water | Insoluble. |
| Dipole moment | ? D |
| Hazards | |
| Main hazards | Irritant. |
| NFPA 704 |
|
| Flash point | Non-flammable. |
| Related Compounds | |
| Related compounds | Cytosine; Adenine; Thymine; Uracil |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
|
WikiDoc Resources for Guanine | |
|
Articles | |
|---|---|
|
Most recent articles on Guanine | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Guanine at Clinical Trials.gov Clinical Trials on Guanine at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Guanine
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating Guanine Risk calculators and risk factors for Guanine
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Guanine | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Guanine is one of the five main nucleobases found in the nucleic acids DNA and RNA; the others being adenine, cytosine, thymine, and uracil. With the formula C5H5N5O, guanine is a derivative of purine, consisting of a fused pyrimidine-imidazole ring system with conjugated double bonds. Being unsaturated, the bicyclic molecule is planar. The guanine nucleoside is called guanosine.
Basic principles
Guanine, along with adenine and cytosine, is present in both DNA and RNA, whereas thymine is usually seen only in DNA and uracil only in RNA. Guanine has two tautomeric forms, the keto form and enol form. It binds to cytosine through three hydrogen bonds. In cytosine, the amino group acts as the hydrogen donor and the C-2 carbonyl and the N-3 amine as the hydrogen-bond acceptors. Guanine has a group at C-6 that acts as the hydrogen acceptor, while the group at N-1 and the amino group at C-2 acts as the hydrogen donors.
Isolation, background, & some chemistry
The first isolation of guanine was reported in 1844 from the excreta of sea birds, known as guano, which was used as a source of fertilizer. About fifty years later, Fischer determined the structure and also showed that uric acid can be converted to guanine. The first complete synthesis was done by Traube and remains among the best large-scale preparations.
Guanine can be hydrolyzed with strong acid to glycine, ammonia, carbon dioxide, and carbon monoxide at 180°C. Guanine oxidizes more readily than adenine, the other purine-derivative base in DNA and RNA. Its high melting point of 350°C reflects the intermolecular hydrogen bonding between the oxo and amino groups in the molecules in the crystal. Because of this intermolecular bonding, guanine is relatively insoluble in water, although it is soluble in dilute acids and bases.
Syntheses
Trace amounts of guanine form by the polymerization of ammonium cyanide (NH4CN). Two experiments conducted by Levy et al., showed that heating 10 M NH4CN at 80°C for 24 hours gave a yield of 0.0007% while using 0.1 M NH4CN frozen at -20°C for 25 years gave a 0.0035% yield. These results indicate guanine could arise in frozen regions of the primitive earth. In 1984, Yuasa reported a 0.00017% yield of guanine after the electrical discharge of NH3, CH4, C2H6, and 50 mL of water, followed by a subsequent acid hydrolysis. However, it is unknown if the presence of guanine was not simply resulted from a contaminant of the reaction.
- 5NH3 + CH4 + 2C2H6 + H2O → C5H8N5O (guanine) + (25/2)H2
A Fischer-Tropsch synthesis can also be used to form guanine, along with adenine, uracil and thymine. Heating an equimolar gas mixture of CO, H2, and NH3 to 700 °C for 0.24 to 0.4 hours, followed by quick cooling and then sustainted reheating to 100-200°C for 16-44 hours with an alumina catalyst yielded guanine and uracil:
- 5CO + (1/2)H2 + 5NH3 → C5H8N5O (guanine) + 4H2O
Traube's synthesis involves heating 2,4,5-triamino-1,6-dihydro-6-oxypyrimidine (as the sulphate) with formic acid for several hours.
Other uses
In 1656 in Paris, François Jaquin (a rosary maker) extracted from scales of some fishes the so called pearl essence, crystalline guanine forming G-quadruplexes: in cosmetic industry, crystalline guanine is used as an additive to various products (e.g., shampoos), where it provides the pearly iridescent effect. It is also used in metallic paints and simulated pearls and plastics. It provides shimmering lustre to eye shadow and nail polish. Guanine crystals are rhombic platelets composed of multiple, transparent layers but they have a high index of refraction that partially reflects and transmits light from layer to layer thus producing a pearly luster. It can be applied by spray, painting or dipping. It may irritate eyes. Its alternatives are mica, synthetic pearl, and aluminium and bronze particles.
See also
References
1. Miyakawa, S., Murasawa, K., Kobayashi, K., Sawaoka, AB. "Abiotic synthesis of guanine with high-temperature plasma." Orig Life Evol Biosph. 30(6): 557-66, Dec. 2000.
2. Horton, H.R., Moran, L.A., Ochs, R.S., Rawn, J.D., Scrimgeour, K.G. "Principles of Biochemistry." Prentice Hall (New Jersey). 3rd Edition, 2002.
3. Lister, J.H. "Part II Purines." The Chemistry of Heterocyclic Compounds. Wiley-Interscience (New York). 1971.
External links
| Nucleobases: | Purine (Adenine, Guanine) | Pyrimidine (Uracil, Thymine, Cytosine) | |
|---|---|---|
| Nucleosides: | Adenosine/Deoxyadenosine | Guanosine/Deoxyguanosine | Uridine | Thymidine | Cytidine/Deoxycytidine | |
| Nucleotides: | monophosphates (AMP, GMP, UMP, CMP) | diphosphates (ADP, GDP, UDP, CDP) | triphosphates (ATP, GTP, UTP, CTP) | cyclic (cAMP, cGMP, cADPR) | |
| Deoxynucleotides: | monophosphates (dAMP, dGMP, TMP, dCMP) | diphosphates (dADP, dGDP, TDP, dCDP) | triphosphates (dATP, dGTP, TTP, dCTP) | |
| Ribonucleic acids: | RNA | mRNA | tRNA | rRNA | gRNA | miRNA | ncRNA | piRNA | shRNA | siRNA | snRNA | snoRNA | |
| Deoxyribonucleic acids: | DNA | mtDNA | cDNA | |
| Nucleic acid analogues: | GNA | LNA | PNA | TNA | morpholino | |
| Cloning vectors: | plasmid | cosmid | fosmid | phagemid | BAC | YAC | HAC | |
WikiDoc Research Resources for Guanine | |
|---|---|
| Articles on Guanine | Most recent articles on Guanine • Most cited articles on Guanine • Review articles on Guanine • Articles on Guanine in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Guanine | Powerpoint slides on Guanine • Images of Guanine • Photos of Guanine • Podcasts & MP3s on Guanine • Videos on Guanine |
| Evidence Based Medicine Regarding Guanine | AND (Cochrane Database Syst Rev[http://worldselectshop.com/?id=9361 Cochrane Collaboration on Guanine • Bandolier on Guanine • TRIP on Guanine |
| Cost Effectiveness of Guanine | AND (Cost effectiveness) |
| group5 = Clinical Trials Involving Guanine | list5 = Ongoing Trials on Guanine at Clinical Trials.gov • Trial results on Guanine • Clinical Trials on Guanine at Google
| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Guanine
| list6 = US National Guidelines Clearinghouse on Guanine • NICE Guidance on Guanine • NHS PRODIGY Guidance • FDA on Guanine • CDC on Guanine
| group7 = Textbook Information on Guanine
| list7 = Books and Textbook Information on Guanine
| group8 = Pharmacology Resources on Guanine
| list8 =
AND (Dose)}} Dosing of Guanine • AND (drug interactions)}} Drug interactions with Guanine • AND (side effects)}} Side effects of Guanine • AND (Allergy)}} Allergic reactions to Guanine • AND (overdose)}} Overdose information on Guanine • AND (carcinogenicity)}} Carcinogenicity information on Guanine • AND (pregnancy)}} Guanine in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Guanine •
| group9 = Genetics, Pharmacogenomics, and Proteinomics of Guanine
| list9 =
AND (pharmacogenomics)}} Genetics of Guanine • AND (pharmacogenomics)}} Pharmacogenomics of Guanine • AND (proteomics)}} Proteomics of Guanine
| group10 = Newstories on Guanine
| list10 = Guanine in the news • Be alerted to news on Guanine • News trends on Guanine</small>
| group11 = Commentary on Guanine
| list11 =
Blogs on Guanine
| group12 = Patient Resources on Guanine | list12 = Patient resources on Guanine • Discussion groups on Guanine • Patient Handouts on Guanine • Directions to Hospitals Treating Guanine • Risk calculators and risk factors for Guanine
| group13 = Healthcare Provider Resources on Guanine
| list13 =
Symptoms of Guanine • Causes & Risk Factors for Guanine • Diagnostic studies for Guanine • Treatment of Guanine
| group14 = Continuing Medical Education (CME) Programs on Guanine | list14 = CME Programs on Guanine
| group15 = International Resources on Guanine | list15 = Guanine en Espanol • Guanine en Francais
| group16 = Business Resources on Guanine | list16 = Guanine in the Marketplace • Patents on Guanine
| group17 = Informatics Resources on Guanine | list17 = List of terms related to Guanine
}}
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies